Genome-Scale Metabolic Model of Infection with SARS-CoV-2 Mutants Confirms Guanylate Kinase as Robust Potential Antiviral Target

dc.contributor.author	Renz, Alina
dc.contributor.author	Dräger, Andreas
dc.date.accessioned	2021-12-14T08:06:53Z
dc.date.available	2021-12-14T08:06:53Z
dc.date.issued	2021
dc.identifier.issn	2073-4425
dc.identifier.uri	http://hdl.handle.net/10900/121719
dc.language.iso	en	de_DE
dc.publisher	Mdpi	de_DE
dc.relation.uri	http://dx.doi.org/10.3390/genes12060796	de_DE
dc.subject.ddc	570	de_DE
dc.subject.ddc	610	de_DE
dc.title	Genome-Scale Metabolic Model of Infection with SARS-CoV-2 Mutants Confirms Guanylate Kinase as Robust Potential Antiviral Target	de_DE
dc.type	Article	de_DE
utue.quellen.id	20210824232002_00921
utue.personen.roh	Renz, Alina
utue.personen.roh	Widerspick, Lina
utue.personen.roh	Draeger, Andreas
dcterms.isPartOf.ZSTitelID	Genes	de_DE
dcterms.isPartOf.ZS-Issue	Article 796	de_DE
dcterms.isPartOf.ZS-Volume	12 (6)	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE
utue.fakultaet	07 Mathematisch-Naturwissenschaftliche Fakultät	de_DE